These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 35458463)

  • 1. Subacute Sclerosing Panencephalitis in Children: The Archetype of Non-Vaccination.
    Papetti L; Amodeo ME; Sabatini L; Baggieri M; Capuano A; Graziola F; Marchi A; Bucci P; D'Ugo E; Kojouri M; Gioacchini S; Marras CE; Nucci CG; Ursitti F; Sforza G; Ferilli MAN; Monte G; Moavero R; Vigevano F; Valeriani M; Magurano F
    Viruses; 2022 Mar; 14(4):. PubMed ID: 35458463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subacute sclerosing panencephalitis mortality, United States, 1979-2016: Vaccine-induced declines in SSPE deaths.
    Pallivathucal LB; Noymer A
    Vaccine; 2018 Aug; 36(35):5222-5225. PubMed ID: 30057285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measles, measles vaccination, and risk of subacute sclerosing panencephalitis (SSPE).
    Zilber N; Rannon L; Alter M; Kahana E
    Neurology; 1983 Dec; 33(12):1558-64. PubMed ID: 6685828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subacute sclerosing panencephalitis: more cases of this fatal disease are prevented by measles immunization than was previously recognized.
    Bellini WJ; Rota JS; Lowe LE; Katz RS; Dyken PR; Zaki SR; Shieh WJ; Rota PA
    J Infect Dis; 2005 Nov; 192(10):1686-93. PubMed ID: 16235165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subacute Sclerosing Panencephalitis: The Devastating Measles Complication That Might Be More Common Than Previously Estimated.
    Wendorf KA; Winter K; Zipprich J; Schechter R; Hacker JK; Preas C; Cherry JD; Glaser C; Harriman K
    Clin Infect Dis; 2017 Jul; 65(2):226-232. PubMed ID: 28387784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subacute sclerosing panencephalitis in The Netherlands--1976-1990.
    Beersma MF; Galama JM; Van Druten HA; Renier WO; Lucas CJ; Kapsenberg JG
    Int J Epidemiol; 1992 Jun; 21(3):583-8. PubMed ID: 1634322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiologic studies of measles, measles vaccine, and subacute sclerosing panencephalitis.
    Modlin JF; Jabbour JT; Witte JJ; Halsey NA
    Pediatrics; 1977 Apr; 59(4):505-12. PubMed ID: 850592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subacute sclerosing panencephalitis in Wales.
    Sussman J; Compston DA
    Q J Med; 1994 Jan; 87(1):23-34. PubMed ID: 8140214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric Subacute Sclerosing Panencephalitis: A Narrative Review on Measles and the Future of Vaccination.
    Sulaiman SA; Vora NM; Chhabra K; Bashir MA; Awan Z
    J Child Neurol; 2024 Mar; 39(3-4):89-97. PubMed ID: 38477320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency, serodiagnosis and epidemiological features of subacute sclerosing panencephalitis (SSPE) and epidemiology and vaccination policy for measles in the Federal Republic of Germany (FRG).
    Enders-Ruckle G
    Dev Biol Stand; 1978; 41():195-207. PubMed ID: 381072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subacute sclerosing panencephalitis in Northern Ireland: twenty years' experience.
    Morrow JI; Dowey KE; Swallow MW
    Ulster Med J; 1986 Oct; 55(2):124-30. PubMed ID: 3811010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Epidemiology of subacute sclerosing panencephalitis in Okinawa, Japan--the second report 1977-1999].
    Hirayasu K; Nakada Y; Oshiro S; Takaesu E; Nakamura K; Shiroma N; Minema H
    No To Hattatsu; 2004 Jan; 36(1):21-5. PubMed ID: 14737859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subacute sclerosing panencephalitis in Bulgaria (1978-2002).
    Bojinova V; Dimova P; Belopitova L; Mihailov A; Gatcheva N; Mihneva Z; Todorova M
    Neuroepidemiology; 2004; 23(5):254-7. PubMed ID: 15316253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subacute sclerosing panencephalitis: clinical phenotype, epidemiology, and preventive interventions.
    Mekki M; Eley B; Hardie D; Wilmshurst JM
    Dev Med Child Neurol; 2019 Oct; 61(10):1139-1144. PubMed ID: 30680706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of subacute sclerosing panencephalitis following measles and measles vaccination in Japan.
    Okuno Y; Nakao T; Ishida N; Konno T; Mizutani H; Fukuyama Y; Sato T; Isomura S; Ueda S; Kitamura I
    Int J Epidemiol; 1989 Sep; 18(3):684-9. PubMed ID: 2807674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subacute sclerosing panencephalitis.
    Garg RK; Mahadevan A; Malhotra HS; Rizvi I; Kumar N; Uniyal R
    Rev Med Virol; 2019 Sep; 29(5):e2058. PubMed ID: 31237061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High risk of subacute sclerosing panencephalitis following measles outbreaks in Georgia.
    Khetsuriani N; Sanadze K; Abuladze M; Tatishvili N
    Clin Microbiol Infect; 2020 Jun; 26(6):737-742. PubMed ID: 31707133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The epidemiology of subacute sclerosing panencephalitis in England and Wales 1990-2002.
    Miller C; Andrews N; Rush M; Munro H; Jin L; Miller E
    Arch Dis Child; 2004 Dec; 89(12):1145-8. PubMed ID: 15557053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Epidemiology of subacute sclerosing panencephalitis in Okinawa, Japan, 1970-1996].
    Hirayasu K; Nakada Y; Takaesu E; Kamiya K; Hirayama K
    No To Hattatsu; 1999 Jan; 31(1):27-31. PubMed ID: 10025131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subacute sclerosing panencephalitis in England and Wales: transient effects and risk estimates.
    Farrington CP
    Stat Med; 1991 Nov; 10(11):1733-44. PubMed ID: 1792467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.